4.7 Article

Long-term results on the suppression of secondary brain injury by early administered low-dose baclofen in a traumatic brain injury mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury

Inge A. M. van Erp et al.

Summary: Traumatic brain injury is a major cause of death and neurofunctional impairment, with neuroinflammation playing a crucial role in secondary brain injury. Attenuating the inflammatory response is a potential therapeutic goal, but non-selective attenuation in the early phase may have detrimental effects. The complement system is involved in the pathophysiology of neuroinflammation after brain injury, suggesting it as a target for therapy.

NEUROTHERAPEUTICS (2023)

Article Clinical Neurology

Acute baclofen administration promotes functional recovery after spinal cord injury

Andreia G. Pinho et al.

Summary: This study aimed to understand the potential of baclofen as a treatment to promote recovery after spinal cord injury (SCI). The results showed that baclofen can improve locomotor and bladder function control in mice after SCI, and it may modulate the immune response. Although further research is needed to explore the mechanisms behind the functional improvements produced by baclofen, this study opens up new avenues for designing pharmacological strategies to promote SCI recovery.

SPINE JOURNAL (2023)

Article Clinical Neurology

Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury

Inge A. M. van Erp et al.

Summary: Traumatic brain injury (TBI) is a major cause of death and disability, and neuroinflammation is a key driver of secondary brain injury after TBI. This review examines the pathophysiology of neuroinflammation and the clinical trials conducted to reduce it. The complement system and its interaction with the coagulation system play an important role in the development of secondary brain injury, making them potential targets for therapy. However, more research is needed to explore specific pathways for pharmacological interventions.

NEUROTHERAPEUTICS (2023)

Article Medicine, General & Internal

18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment

Min Young Chun et al.

Summary: This study suggests that increased 18F-THK5351 uptake may be a useful predictor of cognitive decline among AB- aMCI patients. The patients in the 18F-THK5351-positive group were older and had a faster rate of deterioration in clinical dementia rating-sum of boxes (CDR-SOB) scores.

YONSEI MEDICAL JOURNAL (2022)

Article Behavioral Sciences

On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity-An observational study

Lucas-Michael Halbmayer et al.

Summary: In this retrospective analysis, it was found that intrathecal baclofen treatment can reduce spasticity and have positive effects on recovery of consciousness.

BRAIN AND BEHAVIOR (2022)

Review Biochemistry & Molecular Biology

The Role of Neuroinflammatory Mediators in the Pathogenesis of Traumatic Brain Injury: A Narrative Review

Zuleyha Doganyigit et al.

Summary: Traumatic brain injury (TBI) is a severe neurological disorder with long-term risks of various neurological and neurodegenerative diseases. Neuroinflammatory mediators, particularly inflammatory cytokines, play a crucial role in the functional and pathological outcomes of TBI. Early identification and treatment of these mediators can contribute to the development of more effective treatment options for TBI.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Immunology

Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches

Nirbhay Kumar Prabhakar et al.

Summary: Traumatic brain injury (TBI) is a leading cause of death and morbidity worldwide. Efforts to find neuroprotective therapeutics for TBI have not yielded beneficial outcomes in human clinical trials. Neuroinflammation and the immune system could be potential targets for TBI treatment.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Medicine, General & Internal

Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway

Qiang Li et al.

Summary: Didymin protects neuron cells against cerebral ischemia-reperfusion injury by activating the PPAR pathway and may be a candidate drug for IR treatment.

YONSEI MEDICAL JOURNAL (2022)

Article Immunology

Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury

Philipp Lassaren et al.

Summary: This study found that systemic inflammation, especially infection, can alter cytokine levels with different patterns between the brain and blood. Cerebral inflammatory monitoring provides independent information from arterial and jugular samples, which have similar information content. Additional prospective trials are needed to confirm these associations and explore potential new treatment options for severe TBI patients.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Medicine, Research & Experimental

Improvement of Memory Functions in Chronic Spinal Cord Injury After Long-Term Intrathecal Baclofen Delivery for Spasticity Relief

Ivana Stetkarova et al.

Summary: Long-term administration of ITB did not lead to significant decline in memory functions in SCI subjects, but rather resulted in a significant improvement in short-term auditory-verbal memory and logical memory performance.

NEUROMODULATION (2021)

Article Neurosciences

Sustained Baclofen-Induced Activation of GABAB Receptors After Cerebral Ischemia Restores Receptor Expression and Function and Limits Progressing Loss of Neurons

Mohammad Hleihil et al.

Summary: The activation of GABA(B) receptors with baclofen provides neuroprotection against excitotoxic death in cerebral ischemia. Sustained activation stabilizes receptor expression and reduces downregulation under excitotoxic conditions, preserving GABA(B) receptor-mediated inhibition. This restoration of GABA(B) receptors enhances neuronal survival and function, making them promising targets for neuroprotection in acute cerebral ischemia.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Review Cell Biology

The Complement System: A Powerful Modulator and Effector of Astrocyte Function in the Healthy and Diseased Central Nervous System

Marcela Pekna et al.

Summary: The complement system plays critical roles in the central nervous system, including regulating astrocyte activity. Astrocytes can send and receive complement-related signals by expressing complement proteins and receptors, affecting their environment and neuronal functioning.
Review Chemistry, Multidisciplinary

Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?

Abdullah Al Shoyaib et al.

PHARMACEUTICAL RESEARCH (2020)

Review Biochemistry & Molecular Biology

Management of Traumatic Brain Injury: From Present to Future

Rosalia Crupi et al.

ANTIOXIDANTS (2020)

Review Neurosciences

Brain-Immune Interactions and Neuroinflammation After Traumatic Brain Injury

Virginie Dinet et al.

FRONTIERS IN NEUROSCIENCE (2019)

Article Neurosciences

Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain

Bridgette D. Semple et al.

JOURNAL OF NEUROSCIENCE (2017)

Review Rehabilitation

EFFICACY AND SAFETY OF ORAL BACLOFEN IN THE MANAGEMENT OF SPASTICITY: A RATIONALE FOR INTRATHECAL BACLOFEN

Per Ertzgaard et al.

JOURNAL OF REHABILITATION MEDICINE (2017)

Review Clinical Neurology

The far-reaching scope of neuroinflammation after traumatic brain injury

Dennis W. Simon et al.

NATURE REVIEWS NEUROLOGY (2017)

Review Neurosciences

Neuroimmunology of Traumatic Brain Injury: Time for a ParadigmShift

Yasir N. Jassam et al.

NEURON (2017)

Review Behavioral Sciences

Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?

Sami Piirainen et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)

Article Pharmacology & Pharmacy

A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity

H. W. Heetla et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Review Pharmacology & Pharmacy

The contribution of astrocytes and microglia to traumatic brain injury

Ila P. Karve et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Article Biochemical Research Methods

Neuroinflammation in animal models of traumatic brain injury

Chong-Chi Chiu et al.

JOURNAL OF NEUROSCIENCE METHODS (2016)

Article Neurosciences

Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy

Jonathan D. Cherry et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)

Article Pathology

Possible role of GABA-B receptor modulation in MPTP induced Parkinson's disease in rats

Ravi Kant Tyagi et al.

EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2015)

Article Chemistry, Medicinal

Activation of the γ-Aminobutyric Acid Type B (GABAB) Receptor by Agonists and Positive Allosteric Modulators

Katie M. Brown et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model mice

Woori Kim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Article Clinical Neurology

Progressive Neurodegeneration After Experimental Brain Trauma: Association With Chronic Microglial Activation

David J. Loane et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)

Article Medicine, Research & Experimental

Intrathecal Baclofen Associated With Improvement of Consciousness Disorders in Spasticity Patients

Konstantinos Margetis et al.

NEUROMODULATION (2014)

Article Clinical Neurology

Facilitated Assessment of Tissue Loss Following Traumatic Brain Injury

Anders Hånell et al.

Frontiers in Neurology (2012)

Review Pharmacology & Pharmacy

Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies

David J. Loane et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2010)

Article Critical Care Medicine

Unique challenges in clinical trials in traumatic brain injury

David K. Menon

CRITICAL CARE MEDICINE (2009)

Article Medicine, General & Internal

Pathophysiology of Traumatic Brain Injury

Mark W. Greve et al.

MOUNT SINAI JOURNAL OF MEDICINE (2009)

Review Neurosciences

Molecular dissection of reactive astrogliosis and glial scar formation

Michael V. Sofroniew

TRENDS IN NEUROSCIENCES (2009)

Review Anesthesiology

Pathophysiology of traumatic brain injury

C. Werner et al.

BRITISH JOURNAL OF ANAESTHESIA (2007)

Article Neurosciences

Microglia express GABAB receptors to modulate interleukin release

SA Kuhn et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2004)

Article Behavioral Sciences

Baclofen interactions with nicotine in rats: effects on memory

ED Levin et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)

Article Pharmacology & Pharmacy

Baclofen-impairment of memory retention in rats: possible interaction with adrenoceptor mechanism(s)

MR Zarrindast et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2001)